- Home
- KLC vs ARDX Comparison
KLC vs ARDX Comparison
Compare KLC & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLC
- ARDX
- Stock Information
- Founded
- KLC 1969
- ARDX 2007
- Country
- KLC United States
- ARDX United States
- Employees
- KLC N/A
- ARDX N/A
- Industry
- KLC
- ARDX Biotechnology: Pharmaceutical Preparations
- Sector
- KLC
- ARDX Health Care
- Exchange
- KLC NYSE
- ARDX Nasdaq
- Market Cap
- KLC 1.5B
- ARDX 1.3B
- IPO Year
- KLC 2024
- ARDX 2014
- Fundamental
- Price
- KLC $13.17
- ARDX $3.62
- Analyst Decision
- KLC Buy
- ARDX Strong Buy
- Analyst Count
- KLC 8
- ARDX 8
- Target Price
- KLC $27.88
- ARDX $10.19
- AVG Volume (30 Days)
- KLC 564.3K
- ARDX 6.3M
- Earning Date
- KLC 05-13-2025
- ARDX 05-01-2025
- Dividend Yield
- KLC N/A
- ARDX N/A
- EPS Growth
- KLC N/A
- ARDX N/A
- EPS
- KLC N/A
- ARDX N/A
- Revenue
- KLC $2,663,035,000.00
- ARDX $361,706,000.00
- Revenue This Year
- KLC $6.50
- ARDX $15.74
- Revenue Next Year
- KLC $4.20
- ARDX $34.56
- P/E Ratio
- KLC N/A
- ARDX N/A
- Revenue Growth
- KLC 6.09
- ARDX 127.33
- 52 Week Low
- KLC $10.31
- ARDX $3.62
- 52 Week High
- KLC $29.89
- ARDX $9.20
- Technical
- Relative Strength Index (RSI)
- KLC N/A
- ARDX 32.18
- Support Level
- KLC N/A
- ARDX $3.50
- Resistance Level
- KLC N/A
- ARDX $5.65
- Average True Range (ATR)
- KLC 0.00
- ARDX 0.30
- MACD
- KLC 0.00
- ARDX -0.15
- Stochastic Oscillator
- KLC 0.00
- ARDX 5.59
About KLC KINDERCARE LEARNING COMPANIES INC
KinderCare Learning Companies Inc is a private provider of early childhood education and care services (ECE) in the United States. It serves children ranging from 6 weeks to 12 years of age across its market footprint of around 1,480 early childhood education centers with a capacity of more than 194,000 children and contracts for more than 650 before- and after-school sites located in 40 states and the District of Columbia. Its segment derives revenue from providing early childhood education and care services at centers and before- and after-school sites.
About ARDX Ardelyx Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.